Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

Go back to Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Labranche & Co (NASDAQ: LAB) Delayed: 0.67 --0 (-0%)
Previous Close $0.67    52 Week High $4.47 
Open $0.67    52 Week Low $3.02 
Day High $0.67    P/E N/A 
Day Low $0.67    EPS $-1.56 
Volume 138